244 related articles for article (PubMed ID: 9441300)
21. Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection.
Ruhnke M; Adler A; Müller FM
Clin Microbiol Infect; 2000 Apr; 6(4):220-3. PubMed ID: 11168112
[No Abstract] [Full Text] [Related]
22. [Oesophageal candidiasis: clinical and mycological analysis].
Olmos MA; Araya V; Concetti H; Ramallo J; Piskorz E; Pérez H; Cahn P; Kaufman S; Guelfand L
Acta Gastroenterol Latinoam; 2005; 35(4):211-8. PubMed ID: 16496852
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
[TBL] [Abstract][Full Text] [Related]
24. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Weig M; Müller FM
Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
[TBL] [Abstract][Full Text] [Related]
25. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
Rimek D; Redetzke K; Kappe R
Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
[TBL] [Abstract][Full Text] [Related]
26. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
Hope W; Morton A; Eisen DP
J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
[TBL] [Abstract][Full Text] [Related]
27. Relationship between fluconazole dosage regimens and the emergence of fluconazole-resistant Candida albicans.
Goetz MB
AIDS; 1996 Mar; 10(3):335-6. PubMed ID: 8882674
[No Abstract] [Full Text] [Related]
28. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.
Redding SW; Kirkpatrick WR; Dib O; Fothergill AW; Rinaldi MG; Patterson TF
Spec Care Dentist; 2000; 20(5):178-81. PubMed ID: 11203894
[TBL] [Abstract][Full Text] [Related]
29. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Jandourek A; Brown P; Vazquez JA
Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
[No Abstract] [Full Text] [Related]
30. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
[TBL] [Abstract][Full Text] [Related]
31. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
Małafiej E; Adamiec AC; Tworzyańska U
Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468
[TBL] [Abstract][Full Text] [Related]
32. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
[TBL] [Abstract][Full Text] [Related]
33. Importance of Candida species other than Candida albicans as opportunistic pathogens.
Coleman DC; Rinaldi MG; Haynes KA; Rex JH; Summerbell RC; Anaissie EJ; Li A; Sullivan DJ
Med Mycol; 1998; 36 Suppl 1():156-65. PubMed ID: 9988504
[TBL] [Abstract][Full Text] [Related]
34. Weekly fluconazole to prevent candida.
Gilden D
GMHC Treat Issues; 1996; 10(6/7):16. PubMed ID: 11363636
[TBL] [Abstract][Full Text] [Related]
35. Candida fermentati from HIV patients in Chennai, South India.
Umamaheswari K; Menon T
Int J Infect Dis; 2008 Nov; 12(6):e153-4. PubMed ID: 18650108
[No Abstract] [Full Text] [Related]
36. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
Healy CM; Campbell JR; Zaccaria E; Baker CJ
Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
[TBL] [Abstract][Full Text] [Related]
37. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
Shahid Z; Sobel JD
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
[TBL] [Abstract][Full Text] [Related]
38. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
[TBL] [Abstract][Full Text] [Related]
39. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units].
Gülay Z; Ergon C; Ozkütük A; Yücesoy M; Biçmen M
Mikrobiyol Bul; 2002; 36(3-4):309-16. PubMed ID: 12838665
[TBL] [Abstract][Full Text] [Related]
40. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus.
Baily GG; Moore CB; Essayag SM; de Wit S; Burnie JP; Denning DW
Clin Infect Dis; 1997 Jul; 25(1):161-3. PubMed ID: 9243058
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
